Depression And Alzheimer's Treatments At A Crossroads : Short Wave
Par un écrivain mystérieux
Description
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem. As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease - ScienceDirect
The role of immune inflammation in electroconvulsive therapy for schizophrenia: treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia - ScienceDirect
Exploring the Impact of Coronavirus Disease 2019 on Dementia: A Review - touchNEUROLOGY
Glymphatic failure as a final common pathway to dementia
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance, Psychological Medicine
The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics
Frontiers Frontotemporal disorders: the expansive panoply of syndromes and spectrum of etiologies
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
7 Steps for Igniting the Brain Capital Industrial Strategy
depuis
par adulte (le prix varie selon la taille du groupe)
